The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey

Aged-related declines in cognition, especially working memory and executive function, begin in middle-age and these abilities are known to be mediated by the prefrontal cortex (PFC) and more specifically the dopamine (DA) system within the PFC. In both humans and monkeys, there is significant eviden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tara L. Moore, Damon A. Young, Ronald J. Killiany, Kari R. Fonseca, Dmitri Volfson, David L. Gray, Rita Balice-Gordon, Rouba Kozak
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/de9abf602a974353b8531c96d2cb9afe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de9abf602a974353b8531c96d2cb9afe
record_format dspace
spelling oai:doaj.org-article:de9abf602a974353b8531c96d2cb9afe2021-12-01T07:46:03ZThe Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey1663-436510.3389/fnagi.2021.757850https://doaj.org/article/de9abf602a974353b8531c96d2cb9afe2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.757850/fullhttps://doaj.org/toc/1663-4365Aged-related declines in cognition, especially working memory and executive function, begin in middle-age and these abilities are known to be mediated by the prefrontal cortex (PFC) and more specifically the dopamine (DA) system within the PFC. In both humans and monkeys, there is significant evidence that the PFC is the first cortical region to change with age and the PFC appears to be particularly vulnerable to age-related loss of dopamine (DA). Therefore, the DA system is a strong candidate for therapeutic intervention to slow or reverse age related declines in cognition. In the present study, we administered a novel selective, potent, non-catechol DA D1 R agonist PF-6294 (Pfizer, Inc.) to aged female rhesus monkeys and assessed their performance on two benchmark tasks of working memory – the Delayed Non-match to Sample Task (DNMS) and Delayed Recognition Span Task (DRST). The DNMS task was administered first with the standard 10 s delay and then with 5 min delays, with and without distractors. The DRST was administered each day with four trials with unique sequences and one trial of a repeated sequence to assess evidence learning and retention. Overall, there was no significant effect of drug on performance on any aspect of the DNMS task. In contrast, we demonstrated that a middle range dose of PF-6294 significantly increased memory span on the DRST on the first and last days of testing and by the last day of testing the increased memory span was driven by the performance on the repeated trials.Tara L. MooreTara L. MooreDamon A. YoungRonald J. KillianyRonald J. KillianyKari R. FonsecaDmitri VolfsonDavid L. GrayRita Balice-GordonRouba KozakFrontiers Media S.A.articledopamineagingprefrontal cortexrhesus monkeymemoryNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic dopamine
aging
prefrontal cortex
rhesus monkey
memory
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle dopamine
aging
prefrontal cortex
rhesus monkey
memory
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Tara L. Moore
Tara L. Moore
Damon A. Young
Ronald J. Killiany
Ronald J. Killiany
Kari R. Fonseca
Dmitri Volfson
David L. Gray
Rita Balice-Gordon
Rouba Kozak
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
description Aged-related declines in cognition, especially working memory and executive function, begin in middle-age and these abilities are known to be mediated by the prefrontal cortex (PFC) and more specifically the dopamine (DA) system within the PFC. In both humans and monkeys, there is significant evidence that the PFC is the first cortical region to change with age and the PFC appears to be particularly vulnerable to age-related loss of dopamine (DA). Therefore, the DA system is a strong candidate for therapeutic intervention to slow or reverse age related declines in cognition. In the present study, we administered a novel selective, potent, non-catechol DA D1 R agonist PF-6294 (Pfizer, Inc.) to aged female rhesus monkeys and assessed their performance on two benchmark tasks of working memory – the Delayed Non-match to Sample Task (DNMS) and Delayed Recognition Span Task (DRST). The DNMS task was administered first with the standard 10 s delay and then with 5 min delays, with and without distractors. The DRST was administered each day with four trials with unique sequences and one trial of a repeated sequence to assess evidence learning and retention. Overall, there was no significant effect of drug on performance on any aspect of the DNMS task. In contrast, we demonstrated that a middle range dose of PF-6294 significantly increased memory span on the DRST on the first and last days of testing and by the last day of testing the increased memory span was driven by the performance on the repeated trials.
format article
author Tara L. Moore
Tara L. Moore
Damon A. Young
Ronald J. Killiany
Ronald J. Killiany
Kari R. Fonseca
Dmitri Volfson
David L. Gray
Rita Balice-Gordon
Rouba Kozak
author_facet Tara L. Moore
Tara L. Moore
Damon A. Young
Ronald J. Killiany
Ronald J. Killiany
Kari R. Fonseca
Dmitri Volfson
David L. Gray
Rita Balice-Gordon
Rouba Kozak
author_sort Tara L. Moore
title The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
title_short The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
title_full The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
title_fullStr The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
title_full_unstemmed The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
title_sort effects of a novel non-catechol dopamine partial agonist on working memory in the aged rhesus monkey
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/de9abf602a974353b8531c96d2cb9afe
work_keys_str_mv AT taralmoore theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT taralmoore theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT damonayoung theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ronaldjkilliany theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ronaldjkilliany theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT karirfonseca theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT dmitrivolfson theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT davidlgray theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ritabalicegordon theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT roubakozak theeffectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT taralmoore effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT taralmoore effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT damonayoung effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ronaldjkilliany effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ronaldjkilliany effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT karirfonseca effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT dmitrivolfson effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT davidlgray effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT ritabalicegordon effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
AT roubakozak effectsofanovelnoncatecholdopaminepartialagonistonworkingmemoryintheagedrhesusmonkey
_version_ 1718405447133691904